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Editors’ NotesBoosting Contributions
Not surprisingly, many regenerative medicine strategies involve augmenting endogenous repair processes with new cellular
contributions. Two papers in this issue illustrate advances related to this type of approach. The first, from Martı´nez-Cerden˜o
et al., shows that embryonic MGE cells transplanted into the striatum of adult 6-OHDA-treated rats migrate extensively and differ-
entiate into GABAegic neurons, leading to relief of behavioral symptoms. 6-OHDA treatment is used as a model for Parkinson’s
disease, and although previous work has focused on transplanting dopaminergic neurons to directly replace those lost in the
disease, as Gord Fishell outlines in his preview, cell types acting to change brain circuitry may well suggest a promising new
approach. Oguro et al. look instead at the heart, and at promoting the proliferation of cardiomyocytes. They found that
G-CSF, best known in the stem cell field for HSC mobilization, can promote cardiomyocyte proliferation both in culture and in
embryonic hearts. They go on to show that the same is true for cardiomyocytes differentiated from hESCs or hiPSCs, andthus propose that G-CSF could be used to boost cardiomyocyte yields either
in culture or, potentially, in regenerative therapies in vivo.What’s the Signal?
Environmental factors are key for stem cell regulation in many contexts. Two
articles in this issue look at the way that signaling pathways influence stem cell
properties and proliferation in two very different situations. One, from Greber
and colleagues, looks at signaling pathway activity in mouse EpiSCs and
compares it to hESCs. The comparison is of particular interest because of
the general view that hESCs are more like EpiSCs than mESCs. They findthat the Activin pathway acts similarly in both cell types, promoting pluripotency by activating Nanog expression. However,
they noticed differences when looking at FGF signaling, which, rather than cooperating with SMAD2/3 to also target Nanog,
in EpiSCs seems to act mainly to inhibit neuroectoderm differentiation and help maintain the epiblast state. They also show
that manipulating FGF signaling activity can convert mouse cells between EpiSC and ESC states. In the second study, Butler
et al. look at regulation of HSC proliferation. Their data suggest that a mechanism involving Notch signaling from sinusoidal endo-
thelial cells promotes HSC proliferation and thus assists in hematopoietic recovery after stress. They reached their conclusionsabout Notch signaling on the basis of looking at the ability of endothelial cell
cultures to support HSC expansion in vitro. As North and Goessling discuss in
their preview, these results may point to ways in which recent reports of
a method to expand human cord blood-derived HSCs in culture could be built
and expanded upon.HSCs Give Up Some Secrets
As Timm Schroeder points out in his Minireview, even though HSCs are prob-
ably the best characterized stem cell population, we still have plenty to learn
about them. The Minireview focuses on protocols for isolating HSC popula-
tions and recent evidence that, rather than being governed by a stochastic
differentiation process, HSCs can in fact be divided into lineage-biased
subpopulations. The discussion includes work from Challen et al. in this issue
that describes myeloid and lymphoid-biased HSC subpopulations with differ-ential responsiveness to TGFb signals and then also looks back to a paper from the Iscove lab that used long-term reconstitution
assays to identify intermediate term repopulating cells (ITRCs) in our January issue. Drilling down to the level of chromatin, Oguro
et al. show that the polycomb component Bmi1 plays a similar role in HSCs to that characterized in ESCs, in terms of keeping
genes associated with lineage specification in a ‘‘poised’’ bivalent state, and thus helping to maintain progenitor status. Finally,
in an atypical Forum article, Pulin Li and Leonard Zon describe the course and outcome of an interactive discussion approach
mediated by Dr. Zon that aimed to provide resolution about disagreements that exist regarding the role of N-cadherin in
HSCs. As outlined in the article, a long discussion and experimentation process, taking place over the course of a year, led to
agreement on some issues but not all. On this topic, as on many others, HSCs still have plenty of room to surprise us.Cell Stem Cell 6, March 5, 2010 ª2010 Elsevier Inc. xi
